Parallax Volatility Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parallax Volatility Advisers’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-79,800	Closed	-$9.23M	–	2627
2023 Q3	$9.23M	Sell	79,800 -198,200	-71%	-$21.3M	0.02%	564
2023 Q2	$28.6M	Buy	278,000 +248,500	+842%	+$26.2M	0.06%	254
2023 Q1	$3.22M	Buy	29,500 +400	+1%	+$44.2K	0.01%	1041
2022 Q4	$3.31M	Sell	29,100 -6,800	-19%	-$565K	0.01%	1201
2022 Q3	$2.22M	Buy	35,900 +26,000	+263%	+$1.82M	﹤0.01%	1369
2022 Q2	$791K	Hold	9,900	–	–	﹤0.01%	1729
2022 Q1	$1.04M	Buy	9,900 +4,900	+98%	+$478K	﹤0.01%	1638
2021 Q4	$539K	Hold	5,000	–	–	﹤0.01%	1434
2021 Q3	$548K	Buy	+5,000	New	+$519K	﹤0.01%	1488
2020 Q4	–	Sell	-8,300	Closed	-$645K	–	3407
2020 Q3	$645K	Buy	+8,300	New	+$571K	﹤0.01%	2162
2019 Q2	–	Sell	-50,000	Closed	-$1.32M	–	4211
2019 Q1	$1.32M	Buy	+50,000	New	+$1.18M	﹤0.01%	1152
2018 Q1	–	Sell	-49,900	Closed	-$729K	–	5115
2017 Q4	$729K	Buy	+49,900	New	+$701K	﹤0.01%	1317
2016 Q1	–	Sell	-50,000	Closed	-$1.08M	–	4130
2015 Q4	$1.08M	Hold	50,000	–	–	﹤0.01%	1245
2015 Q3	$991K	Buy	+50,000	New	+$1.58M	﹤0.01%	1293

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parallax Volatility Advisers's HZNP Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 18,019 shares — an estimated $2.08M sold.

Parallax Volatility Advisers first reported a position in HZNP in Q3 2015 and held it in 14 quarters. The position peaked at $2.08M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Parallax Volatility Advisers reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 18,019 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.08M.
Parallax Volatility Advisers first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 14 quarters.
Parallax Volatility Advisers's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.08M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.